SEC Form 4 · accession 0001213900-26-069424
Tiziana Life Sciences Ltd · TLSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Gabriele M Cerrone
Director · 10% Owner
Period of report
Jun 12, 2026
Accepted (ET)
Jun 17, 2026 · 6:31 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001723069
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jun 12, 2026 | A | 15,000 | $1.11 | A | 44,772,230 | I | Via Panetta Partners Limited |
Table II — derivative securities
No Table II lines on this filing.